Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1,2-dioleoyl Glycerophosphocholine
2. 1,2-dioleoyl-sn-glycerol-3-ethylphosphocholine
3. 1,2-dioleoylglycerophosphocholine
4. 1,2-docpc
5. 1,2-oleoyl-sn-glycero-3-phosphocholine
6. 1,2-oleoylphosphatidylcholine
7. 1,2-oleoylphosphatidylcholine, (e,e)-isomer
8. 1,2-oleoylphosphatidylcholine, (l-alpha)-(r-(z,z))-isomer
9. 1,2-oleoylphosphatidylcholine, (r-(e,e))-isomer
10. 1,2-oleoylphosphatidylcholine, (z,z)-(+-)-isomer
11. 1,2-oleoylphosphatidylcholine, 14c-labeled, (r-(z,z))-isomer
12. Dielaidinoyl Lecithin
13. Dielaidoylphosphatidylcholine
14. Dioleoyl Lecithin
15. Dioleoyl Phosphatidylcholine
16. Dioleoylphosphatidylcholine
17. Dioleoylphosphatidylcholine, Dl-
18. Dioleylphosphatidylcholine
19. Dopc
1. 4235-95-4
2. Dopc
3. Pc(18:1(9z)/18:1(9z))
4. 1,2-dioleoyl-l-alpha-lecithin
5. (r)-2,3-bis(oleoyloxy)propyl (2-(trimethylammonio)ethyl) Phosphate
6. 1,2-di-(9z-octadecenoyl)-sn-glycero-3-phosphocholine
7. H026dm5v6u
8. Pc(18:1/18:1)
9. (r)-2,3-bis(oleoyloxy)propyl [2-(trimethylammonio)ethyl] Phosphate
10. Choline Phosphate, 3-ester With L-1,2-diolein
11. (r-(z,z))-(7-oleoyl-4-oxido-10-oxo-3,5,9-trioxa-4-phosphaheptacos-18-enyl)trimethylammonium 4-oxide
12. Olein, 1,2-di-, L-, Dihydrogen Phosphate, Monoester With Choline Hydroxide
13. Pc 18:1
14. Pc 36:2
15. [(2r)-2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl] 2-(trimethylazaniumyl)ethyl Phosphate
16. Choline, Hydroxide, Dihydrogen Phosphate, Inner Salt, Ester With L-1,2-diolein
17. Dioleoylphosphatidylcholine
18. Unii-h026dm5v6u
19. 1,2-dioleoyllec
20. Einecs 224-193-8
21. Mfcd00135191
22. Phosphatidylcholine 18:1
23. Dopc, L-
24. Dopc, R-
25. Schembl24888
26. 1,2-dioleoyl-sn-glycero-3-pc
27. Chebi:74669
28. Pdd 111
29. Dtxsid101274283
30. (z,z)-(1)-(7-oleoyl-4-oxido-10-oxo-3,5,9-trioxa-4-phosphaheptacos-18-enyl)trimethylammonium 4-oxide
31. Lmgp01010890
32. 1-oleoyl-2-oleoyl-phosphatidylcholine
33. Akos024418773
34. 1-18:1-2-18:1-phosphatidylcholine
35. Hy-113424a
36. Dioleoyl Phosphatidylcholine, L-
37. Dioleoyl Phosphatidylcholine, R-
38. As-72051
39. Bp-25710
40. 1,2-dioleoyl-rac-glycero-3-phosphocholine
41. 1, 2-dioleoyl-sn-glycero-3-phosphocholine
42. 1,2-dioleoyl-sn-glycero-3-phosphocho-line
43. Cs-0063306
44. D4250
45. 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine
46. 18:1-18:1-pc
47. 1-18:1-2-18:1-sn--glycerol-3-phosphocholine
48. A872903
49. Sn-glycerol-3-phosphocholine (1-18:1-2-18:1)
50. W-202732
51. 1,2-(9z-octadecenoyl)-sn--glycero-3-phosphocholine
52. Q27144815
53. 1,2-dioleoyl-sn-glycero-3-phosphocholine [ii]
54. 1-c18:1(omega-9)-2-c18:1(omega-9)-phosphatidylcholine
55. N,n,n-trimethyl 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
56. (r)-2,3-bis(oleoyloxy)propyl(2-(trimethylammonio)ethyl)phosphate
57. 1-(9z)-octadecenoyl-2-(9z)-octadecenoyl-sn-glycero-3-phosphocholine
58. (2-{[(2r)-2,3-bis[(9z)-octadec-9-enoyloxy]propyl Phosphonato]oxy}ethyl)trimethylazanium
59. (2r)-2,3-bis[(9z)-octadec-9-enoyloxy]propyl 2-(trimethylazaniumyl)ethyl Phosphate
60. [(2s)-2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl] 2-(trimethylazaniumyl)ethyl Phosphate
61. 18:1 (delta9-cis) Pc (dopc), 1,2-dioleoyl-sn-glycero-3-phosphocholine, Powder
62. (z,z)-4-hydroxy-n,n,n-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-3,5,9-trioxa-4-phosphaheptacos-18-en-1-aminium 4-oxide Hydroxide Inner Salt
63. 3,5,9-trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, Inner Salt, 4-oxide, [r-(z,z)]-
Molecular Weight | 786.1 g/mol |
---|---|
Molecular Formula | C44H84NO8P |
XLogP3 | 13.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 42 |
Exact Mass | 785.59345564 g/mol |
Monoisotopic Mass | 785.59345564 g/mol |
Topological Polar Surface Area | 111 Ų |
Heavy Atom Count | 54 |
Formal Charge | 0 |
Complexity | 972 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
92
PharmaCompass offers a list of DOPC API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right DOPC manufacturer or DOPC supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred DOPC manufacturer or DOPC supplier.
PharmaCompass also assists you with knowing the DOPC API Price utilized in the formulation of products. DOPC API Price is not always fixed or binding as the DOPC Price is obtained through a variety of data sources. The DOPC Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]-, including repackagers and relabelers. The FDA regulates 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- supplier is an individual or a company that provides 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- active pharmaceutical ingredient (API) or 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- finished formulations upon request. The 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- suppliers may include 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- API manufacturers, exporters, distributors and traders.
click here to find a list of 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- DMF (Drug Master File) is a document detailing the whole manufacturing process of 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- active pharmaceutical ingredient (API) in detail. Different forms of 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- DMFs exist exist since differing nations have different regulations, such as 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- DMF submitted to regulatory agencies in the US is known as a USDMF. 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- USDMF includes data on 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]-'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- suppliers with USDMF on PharmaCompass.
3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- GMP manufacturer or 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- GMP API supplier for your needs.
A 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- CoA (Certificate of Analysis) is a formal document that attests to 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]-'s compliance with 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- specifications and serves as a tool for batch-level quality control.
3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- CoA mostly includes findings from lab analyses of a specific batch. For each 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- may be tested according to a variety of international standards, such as European Pharmacopoeia (3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- EP), 3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-octadecenyl)oxy]-, inner salt, 4-oxide, [R-(Z,Z)]- USP).